A New Roadmap for Repairing the Damage of Multiple Sclerosis

We are proud to have collaborated with the Drew Adams lab on an exciting study published today in the journal Nature. The study defined a unifying mechanism by which small molecules stimulate the generation of new oligodendrocytes and enhance remyelination. This discovery will accelerate efforts to develop safe and effective medicines for patients with MS and other myelin disorders.

Click Here to Read the Paper
Click Here to Read the Press Release

News Category: